Status:
COMPLETED
Early Discharge in Patients Undergoing Elbow Arthroscopy
Lead Sponsor:
University Health Network, Toronto
Conditions:
Elbow Arthroscopy Surgery
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Patients undergoing elbow arthroscopy surgery will receive standard anesthesia and analgesia (infraclavicular nerve block combined with general anesthesia for surgery; continuous infusion via infracla...
Eligibility Criteria
Inclusion
- Patients undergoing elective complex arthroscopic elbow surgery requiring postoperative CPM - synovectomy, capsulectomy, extensive debridement, contracture release, osteocapsular arthroplasty.
- ASA I-III
Exclusion
- Age\>65
- Cognitively challenged patients
- Severe COPD
- Patients who, on their own or with the assistance of a caregiver, are not confident of being able to remove the local anesthetic infusion catheter at home
- Psychiatric history
- Allergy to ropivacaine.
- Opioid tolerance (\>60mg oral morphine or equivalent/day)
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01151241
Start Date
July 1 2010
End Date
December 1 2014
Last Update
February 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Western Hospital
Toronto, Ontario, Canada, M5T 2S8